News & Analysis as of

Divestiture Drug Pricing Federal Trade Commission (FTC)

Goodwin

Antitrust & Competition Healthcare Quarterly Update Q2 2025

Goodwin on

Healthcare remains a key area of focus for antitrust regulators in the first six months of the Trump administration. The Federal Trade Commission (FTC) and the Department of Justice (DOJ) have for the most part stuck to prior...more

McDermott Will & Schulte

FTC Ratchets up Scrutiny on Pharmaceutical Deals

McDermott Will & Schulte on

WHAT HAPPENED: • Recent developments indicate that pharmaceutical deals are attracting greater scrutiny from the Federal Trade Commission (FTC). • In September 2019, FTC Chairman Joseph Simons reportedly stated that the...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide